XOMA (NASDAQ:XOMAP) Trading 0.2% Higher – Should You Buy?

Shares of XOMA Co. (NASDAQ:XOMAPGet Free Report) were up 0.2% during mid-day trading on Tuesday . The company traded as high as $26.49 and last traded at $26.6190. Approximately 390 shares changed hands during mid-day trading, a decline of 75% from the average daily volume of 1,555 shares. The stock had previously closed at $26.56.

XOMA Price Performance

The firm has a 50-day moving average of $26.44 and a 200 day moving average of $26.04.

XOMA Company Profile

(Get Free Report)

XOMA Royalty Corporation operates as a biotech royalty aggregator in the United States and the Asia Pacific. It has a portfolio of economic rights to future potential milestone and royalty payments associated with partnered commercial and pre-commercial therapeutic candidates. The company also focuses on early to mid-stage clinical assets primarily in Phase 1 and 2 with commercial sales potential that are licensed to partners; and acquires milestone and royalty revenue streams on late-stage clinical or commercial assets.

Featured Articles

Receive News & Ratings for XOMA Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for XOMA and related companies with MarketBeat.com's FREE daily email newsletter.